Inscobee Raises 5 Billion Won via 10 Million Share Third-Party Allotment for Operations and Debt Repayment, Dilution of 6.8% and Weak Counterparty Financials Raise Concerns
Inscobee resolved on April 30, 2026 to issue 10 million common shares at 500 KRW per share via a third-party allotment, with the payment date corrected to August 28, 2026.
The issuance price is at a 67% premium to the current market price of 299 KRW, limiting dilution impact, but the 6.8% dilution relative to outstanding shares is still notable.
The 5 billion KRW raised will be used for operating expenses of 2.428 billion KRW and early redemption of convertible bonds series 32 to 36 totaling 2.572 billion KRW.
The counterparty, Nemo Bio Ventures, is a financially weak entity with negative equity of 66 million KRW, posing governance risk, though the shares are locked up for one year.
[AI Summary]Inscobee's capital increase is a defensive move to cover operating costs and repay debt, with a 6.8% dilution and a risky counterparty that could undermine shareholder value, partially offset by the premium issue price.
KOSPI Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)